IMBiotechnologies produces Ekboi Embolization Microspheres, a biodegradable embolic agent that is detectable by ultrasound. It is approved in the U.S. for treatment of unresectable/inoperable hypervascularized tumors.
Through the new partnership, Embol will be able to provide Ekobi microspheres to its ASC partners, according to a Feb. 21 press release.
